Summit Securities Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-643
Closed -$1.13M 1026
2021
Q3
$1.13M Buy
+643
New +$7.51K 0.09% 240

Other funds holding TRIL